<i>pncCCND1_B</i> Engages an Inhibitory Protein Network to Downregulate <i>CCND1</i> Expression upon DNA Damage

Promoter-associated noncoding RNAs (pancRNAs) represent a class of noncoding transcripts driven from the promoter region of protein-coding or non-coding genes that operate as cis-acting elements to regulate the expression of the host gene. PancRNAs act by altering the chromatin structure and recruit...

Full description

Bibliographic Details
Main Authors: Ramona Palombo, Maria Paola Paronetto
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/6/1537
_version_ 1797446917292032000
author Ramona Palombo
Maria Paola Paronetto
author_facet Ramona Palombo
Maria Paola Paronetto
author_sort Ramona Palombo
collection DOAJ
description Promoter-associated noncoding RNAs (pancRNAs) represent a class of noncoding transcripts driven from the promoter region of protein-coding or non-coding genes that operate as cis-acting elements to regulate the expression of the host gene. PancRNAs act by altering the chromatin structure and recruiting transcription regulators. <i>PncCCND1_B</i> is driven by the promoter region of <i>CCND1</i> and regulates <i>CCND1</i> expression in Ewing sarcoma through recruitment of a multi-molecular complex composed of the RNA binding protein Sam68 and the DNA/RNA helicase DHX9. In this study, we investigated the regulation of <i>CCND1</i> expression in Ewing sarcoma cells upon exposure to chemotherapeutic drugs. Pan-inhibitor screening indicated that etoposide, a drug used for Ewing sarcoma treatment, promotes transcription of <i>pncCCND1_B</i> and repression of <i>CCND1</i> expression. RNA immunoprecipitation experiments showed increased binding of Sam68 to the <i>pncCCND1_B</i> after treatment, despite the significant reduction in DHX9 protein. This effect was associated with the formation of DNA:RNA duplexes at the <i>CCND1</i> promoter. Furthermore, Sam68 interacted with HDAC1 in etoposide treated cells, thus contributing to chromatin remodeling and epigenetic changes. Interestingly, inhibition of the ATM signaling pathway by KU 55,933 treatment was sufficient to inhibit etoposide-induced Sam68-HDAC1 interaction without rescuing DHX9 expression. In these conditions, the DNA:RNA hybrids persist, thus contributing to the local chromatin inactivation at the <i>CCND1</i> promoter region. Altogether, our results show an active role of Sam68 in DNA damage signaling and chromatin remodeling on the <i>CCND1</i> gene by fine-tuning transitions of epigenetic complexes on the <i>CCND1</i> promoter.
first_indexed 2024-03-09T13:47:29Z
format Article
id doaj.art-c1dec3da18a446fca214b37fe07f1491
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T13:47:29Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-c1dec3da18a446fca214b37fe07f14912023-11-30T20:56:48ZengMDPI AGCancers2072-66942022-03-01146153710.3390/cancers14061537<i>pncCCND1_B</i> Engages an Inhibitory Protein Network to Downregulate <i>CCND1</i> Expression upon DNA DamageRamona Palombo0Maria Paola Paronetto1Laboratory of Molecular and Cellular Neurobiology, IRCCS Fondazione Santa Lucia, 00143 Rome, ItalyLaboratory of Molecular and Cellular Neurobiology, IRCCS Fondazione Santa Lucia, 00143 Rome, ItalyPromoter-associated noncoding RNAs (pancRNAs) represent a class of noncoding transcripts driven from the promoter region of protein-coding or non-coding genes that operate as cis-acting elements to regulate the expression of the host gene. PancRNAs act by altering the chromatin structure and recruiting transcription regulators. <i>PncCCND1_B</i> is driven by the promoter region of <i>CCND1</i> and regulates <i>CCND1</i> expression in Ewing sarcoma through recruitment of a multi-molecular complex composed of the RNA binding protein Sam68 and the DNA/RNA helicase DHX9. In this study, we investigated the regulation of <i>CCND1</i> expression in Ewing sarcoma cells upon exposure to chemotherapeutic drugs. Pan-inhibitor screening indicated that etoposide, a drug used for Ewing sarcoma treatment, promotes transcription of <i>pncCCND1_B</i> and repression of <i>CCND1</i> expression. RNA immunoprecipitation experiments showed increased binding of Sam68 to the <i>pncCCND1_B</i> after treatment, despite the significant reduction in DHX9 protein. This effect was associated with the formation of DNA:RNA duplexes at the <i>CCND1</i> promoter. Furthermore, Sam68 interacted with HDAC1 in etoposide treated cells, thus contributing to chromatin remodeling and epigenetic changes. Interestingly, inhibition of the ATM signaling pathway by KU 55,933 treatment was sufficient to inhibit etoposide-induced Sam68-HDAC1 interaction without rescuing DHX9 expression. In these conditions, the DNA:RNA hybrids persist, thus contributing to the local chromatin inactivation at the <i>CCND1</i> promoter region. Altogether, our results show an active role of Sam68 in DNA damage signaling and chromatin remodeling on the <i>CCND1</i> gene by fine-tuning transitions of epigenetic complexes on the <i>CCND1</i> promoter.https://www.mdpi.com/2072-6694/14/6/1537Sam68noncoding RNAEwing sarcoma<i>CCND1</i>DNA damage
spellingShingle Ramona Palombo
Maria Paola Paronetto
<i>pncCCND1_B</i> Engages an Inhibitory Protein Network to Downregulate <i>CCND1</i> Expression upon DNA Damage
Cancers
Sam68
noncoding RNA
Ewing sarcoma
<i>CCND1</i>
DNA damage
title <i>pncCCND1_B</i> Engages an Inhibitory Protein Network to Downregulate <i>CCND1</i> Expression upon DNA Damage
title_full <i>pncCCND1_B</i> Engages an Inhibitory Protein Network to Downregulate <i>CCND1</i> Expression upon DNA Damage
title_fullStr <i>pncCCND1_B</i> Engages an Inhibitory Protein Network to Downregulate <i>CCND1</i> Expression upon DNA Damage
title_full_unstemmed <i>pncCCND1_B</i> Engages an Inhibitory Protein Network to Downregulate <i>CCND1</i> Expression upon DNA Damage
title_short <i>pncCCND1_B</i> Engages an Inhibitory Protein Network to Downregulate <i>CCND1</i> Expression upon DNA Damage
title_sort i pncccnd1 b i engages an inhibitory protein network to downregulate i ccnd1 i expression upon dna damage
topic Sam68
noncoding RNA
Ewing sarcoma
<i>CCND1</i>
DNA damage
url https://www.mdpi.com/2072-6694/14/6/1537
work_keys_str_mv AT ramonapalombo ipncccnd1biengagesaninhibitoryproteinnetworktodownregulateiccnd1iexpressionupondnadamage
AT mariapaolaparonetto ipncccnd1biengagesaninhibitoryproteinnetworktodownregulateiccnd1iexpressionupondnadamage